Research graph
References from Rethinking Prevention of Recurrent Bacterial Vaginosis: A Comparative Effectiveness Network Meta-Analysis. Local targets link to admitted publications; unresolved targets remain external evidence.
Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis
10.1016/s1701-2163(15)30316-9 · 2015 · External reference
Bacterial vaginosis: a synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infections
2016 · External reference
Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies
10.1097/qad.0b013e3283021a37 · 2008 · External reference
Bacterial vaginosis and surgical site infections
10.1016/j.ajog.2019.09.002 · 2020 · External reference
No. 211: screening and management of bacterial vaginosis in pregnancy
10.1016/j.jogc.2017.04.018 · 2017 · External reference
Bacterial vaginosis: a review of approaches to treatment and prevention
10.3389/frph.2023.1100029 · 2023 · External reference
Characterization and treatment of recurrent bacterial vaginosis
10.1089/jwh.2018.7383 · 2019 · External reference
Systematic review of randomized trials of treatment of male sexual partners for improved bacterial vaginosis outcomes in women
10.1097/olq.0b013e3182631d89 · 2012 · External reference
Combined oral and topical antimicrobial therapy for male partners of women with bacterial vaginosis: acceptability, tolerability and impact on the genital microbiota of couples—a pilot study
10.1371/journal.pone.0190199 · 2018 · External reference
RoB 2: a revised tool for assessing risk of bias in randomised trials
10.1136/bmj.l4898 · 2019 · External reference
CINeMA: an approach for assessing confidence in the results of a network meta-analysis
10.1371/journal.pmed.1003082 · 2020 · External reference
meta: an R package for meta-analysis
2007 · External reference
Ranking treatments in frequentist network meta-analysis works without resampling methods
10.1186/s12874-015-0060-8 · 2015 · External reference
Conducting meta-analyses in R with the metafor package
10.18637/jss.v036.i03 · 2010 · External reference
Comparison of single-dose vs one-week course of metronidazole for symptomatic bacterial vaginosis
10.1001/jama.1985.03360080058029 · 1985 · External reference
Effect of a yoghurt drink containing Lactobacillus strains on bacterial vaginosis in women—a double-blind, randomised, controlled clinical pilot trial
10.3920/bm2017.0018 · 2018 · External reference
Efficacy of the combination of 2 g oral tinidazole and acidic buffering vaginal gel in comparison with vaginal clindamycin alone in bacterial vaginosis: a randomized, investigator-blinded, controlled trial
10.1016/s0301-2115(02)00478-5 · 2003 · External reference
The role of Lactobacillus casei rhamnosus Lcr35 in restoring the normal vaginal flora after antibiotic treatment of bacterial vaginosis
10.1111/j.1471-0528.2008.01882.x · 2008 · External reference
Probiotics reduce the recurrence of asymptomatic bacterial vaginosis in Chinese women
10.1038/s41598-025-92843-7 · 2025 · External reference
Male-partner treatment to prevent recurrence of bacterial vaginosis
10.1056/nejmoa2405404 · 2025 · External reference
Bacterial vaginosis: a double-blind randomized trial of the effect of treatment of the sexual partner
10.1111/j.1471-0528.1988.tb06581.x · 1988 · External reference
Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis
10.1016/j.ajog.2005.11.041 · 2006 · External reference
A randomized double-blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis
1993 · External reference
Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study
10.1016/j.ajog.2010.05.023 · 2010 · External reference
Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use
10.1093/cid/cis1030 · 2013 · External reference
Effectiveness of vaginal administration of Lactobacillus rhamnosus following conventional metronidazole therapy: how to lower the rate of bacterial vaginosis recurrences
2008 · External reference
Long-term vaginal administration of Lactobacillus rhamnosus as a complementary approach to management of bacterial vaginosis
10.1016/j.ijgo.2010.04.025 · 2010 · External reference
Exploring potential of vaginal Lactobacillus isolates from South African women for enhancing treatment for bacterial vaginosis
10.1371/journal.ppat.1008559 · 2020 · External reference
Prevention of recurrence of bacterial vaginosis using lactobacilli-containing vaginal tablets among women with HIV: a randomized, placebo-controlled, double-blinded phase IV trial
10.1016/j.ijid.2023.02.003 · 2023 · External reference
Efficacy and safety of vaginally administered lyophilized Lactobacillus crispatus IP 174178 in the prevention of bacterial vaginosis recurrence
10.1016/j.jogoh.2017.11.005 · 2018 · External reference
Safety and efficacy of an intravaginal prebiotic gel in the prevention of recurrent bacterial vaginosis: a randomized double-blind study
10.1155/2012/147867 · 2012 · External reference
Metronidazole with Lactacyd vaginal gel in bacterial vaginosis
10.1111/j.1447-0756.2006.00383.x · 2006 · External reference
Orally administrated Lactobacillus gasseri TM13 and Lactobacillus crispatus LG55 can restore the vaginal health of patients recovering from bacterial vaginosis
10.3389/fimmu.2023.1125239 · 2023 · External reference
Treatment of biofilms in bacterial vaginosis by an amphoteric tenside pessary-clinical study and microbiota analysis
10.1186/s40168-017-0326-y · 2017 · External reference
The effect of prebiotic vaginal gel with adjuvant oral metronidazole tablets on treatment and recurrence of bacterial vaginosis: a triple-blind randomized controlled study
10.1007/s00404-017-4555-x · 2018 · External reference
Effect of the vaginal live biotherapeutic LACTIN-V (Lactobacillus crispatus CTV-05) on vaginal microbiota and genital tract inflammation among women at high risk of HIV acquisition in South Africa: a phase 2, randomised, placebo-controlled trial
10.1016/j.lanmic.2024.101037 · 2025 · External reference
Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV
10.1016/j.ijgo.2010.07.008 · 2010 · External reference
Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: a randomised, double-blind, placebo-controlled trial
10.1186/s12905-015-0246-6 · 2015 · External reference
Efficacy of vitamin C vaginal tablets as prophylaxis for recurrent bacterial vaginosis: a randomised, double-blind, placebo-controlled clinical trial
2013 · External reference
Treatment of male sexual partners of women with bacterial vaginosis: a randomized, double-blind, placebo-controlled trial
10.1093/cid/ciaa1903 · 2021 · External reference
Oral intake of Lactobacilli can be helpful in symptomatic bacterial vaginosis: a randomized clinical study
10.1097/lgt.0000000000000518 · 2020 · External reference
Intermittent Lactobacilli-containing vaginal probiotic or metronidazole use to prevent bacterial vaginosis recurrence: a pilot study incorporating microscopy and sequencing
10.1038/s41598-020-60671-6 · 2020 · External reference
Intermittent intravaginal antibiotic treatment of bacterial vaginosis in HIV-uninfected and -infected women: a randomized clinical trial
10.1371/journal.pctr.0020010 · 2007 · External reference
Randomized trial of lactin-V to prevent recurrence of bacterial vaginosis
10.1056/nejmoa1915254 · 2020 · External reference
Metronidazole combined with nystatin (vagitories) in the prevention of bacterial vaginosis after initial treatment with oral metronidazole
1993 · External reference
Comparing the efficacy of probiotic plus antibiotic with the antibiotic therapy alone on the recurrence of bacterial vaginosis
2025 · External reference
Probiotic Lacticaseibacillus rhamnosus GR-1 and Limosilactobacillus reuteri RC-14 as an adjunctive treatment for bacterial vaginosis do not increase the cure rate in a chinese cohort: a prospective, parallel-group, randomized, controlled study
10.3389/fcimb.2021.669901 · 2021 · External reference
A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis
2021 · External reference
Effect of oral supplementation of the probiotic capsule UB-01BV in the treatment of patients with bacterial vaginosis
10.3920/bm2011.0054 · 2012 · External reference
Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection
10.1186/s12879-015-0971-3 · 2015 · External reference
An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in South African women with bacterial vaginosis
10.1186/s12879-019-4425-1 · 2019 · External reference
Evidence-based mixture containing Lactobacillus strains and lactoferrin to prevent recurrent bacterial vaginosis: a double blind, placebo controlled, randomised clinical trial
10.3920/bm2018.0075 · 2019 · External reference
Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study
10.1186/1472-6874-8-3 · 2008 · External reference
A double-blind treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open treatment with vaginal clindamycin ovules
10.1080/00015550410022249 · 2005 · External reference
Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial
1997 · External reference
Should male consorts of women with bacterial vaginosis be treated?
1989 · External reference
Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis
10.1016/j.micinf.2006.08.008 · 2006 · External reference
Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial
10.1139/w08-102 · 2009 · External reference
The addition of vitamin C vaginal tablets to oral metronidazole and its effect on the treatment and recurrence of bacterial vaginosis: a randomized triple-blind clinical trial
2017 · External reference
Garnerella-associated vaginitis: comparison of three treatment modalities
1998 · External reference
Antibiotic treatment for the sexual partners of women with bacterial vaginosis
2016 · External reference
Male partner treatment and the potential sexual transmission of bacterial vaginosis: considerations for patient counseling and clinical application in the United States
10.1016/j.ajog.2025.11.001 · 2026 · External reference
Probiotics, a promising therapy to reduce the recurrence of bacterial vaginosis in women: a systematic review and meta-analysis of randomized controlled trials
10.3389/fnut.2022.938838 · 2022 · External reference
Intravaginal vitamin C for the treatment and prevention of bacterial vaginosis: a systematic review and meta-analysis
10.1097/aog.0000000000006092 · 2025 · External reference
Probiotics for the treatment of bacterial vaginosis
2009 · External reference
Treating vaginitis with probiotics in non-pregnant females: a systematic review and meta-analysis
2020 · External reference
Probiotics for the treatment of women with bacterial vaginosis: a systematic review and meta-analysis of randomized clinical trials
10.1016/j.ejphar.2019.172660 · 2019 · External reference
Hydrogen peroxide-producing lactobacilli are associated with lower levels of vaginal interleukin-1β independent of bacterial vaginosis
10.1097/olq.0000000000000298 · 2015 · External reference
Comparative genomics of Lactobacillus crispatus suggests novel mechanisms for the competitive exclusion of Gardnerella vaginalis
10.1186/1471-2164-15-1070 · 2014 · External reference